Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells PD Rädler, BL Wehde, KU Wagner Molecular and cellular endocrinology 451, 31-39, 2017 | 78 | 2017 |
Janus kinase 1 plays a critical role in mammary cancer progression BL Wehde, PD Rädler, H Shrestha, SJ Johnson, AA Triplett, KU Wagner Cell reports 25 (8), 2192-2207. e5, 2018 | 50 | 2018 |
Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells PD Rädler, BL Wehde, AA Triplett, H Shrestha, JH Shepherd, AD Pfefferle, ... Nature communications 12 (1), 3742, 2021 | 41 | 2021 |
Janus kinase 1 is essential for inflammatory cytokine signaling and mammary gland remodeling K Sakamoto, BL Wehde, KH Yoo, T Kim, N Rajbhandari, HY Shin, ... Molecular and cellular biology 36 (11), 1673-1690, 2016 | 39 | 2016 |
Generation of Janus kinase 1 (JAK1) conditional knockout mice K Sakamoto, BL Wehde, PD Rädler, AA Triplett, KU Wagner genesis 54 (11), 582-588, 2016 | 20 | 2016 |
High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer C Lim, D Hwang, M Yazdimamaghani, HM Atkins, H Hyun, Y Shin, ... Nano Today 51, 101884, 2023 | 11 | 2023 |
Efficient tissue-type specific expression of target genes in a tetracycline-controlled manner from the ubiquitously active Eef1a1 locus K Sakamoto, PD Rädler, BL Wehde, AA Triplett, H Shrestha, ... Scientific Reports 10 (1), 207, 2020 | 5 | 2020 |
Dual recombinase action in the normal and neoplastic mammary gland epithelium PD Rädler, K Vistisen, AA Triplett, R Dennaoui, Y Li, H Shrestha, ... Scientific Reports 11 (1), 20775, 2021 | 3 | 2021 |
Combination of polymeric micelle formulation of TGFβ receptor inhibitors and paclitaxel produces consistent response across different mouse models of Triple‐negative breast cancer N Vinod, D Hwang, SC Fussell, TC Owens, OC Tofade, TS Benefield, ... Bioengineering & Translational Medicine, e10681, 2024 | | 2024 |
The Janus kinase 1 is critical for pancreatic cancer initiation and progression H Shrestha, PD Rädler, R Dennaoui, MN Wicker, N Rajbhandari, Y Sun, ... Cell Reports 43 (5), 2024 | | 2024 |
The Cellular Origin and Molecular Drivers of Claudin-Low Mammary Cancer PD Raedler | | 2020 |